vaccine manufacturers

Top 3 Sparks of Interest for Leading Vaccine Academics

Recently we undertook the research for the 15th annual World Vaccine Congress. As part of that research, we spoke to leading vaccine academics from the likes of University of Oxford and Erasmus MC to find out what they thought were the most interesting trends in industry at the moment. These were the top 3: 1. The renaissance of veterinary vaccines …

Vaccine Asia Live: NIAID’s Effort on Dengue Vaccine R&D

Addressing Asia’s needs for vaccines in dengue, Dr Zou Lanling, Bacteriology Program Officer & Chief of Translational Sciences Section of National Institutes of Health USA, shared the efforts put into dengue vaccine R&D by National Institute of Allergy and Infectious Diseases(NIAID). NIAID conducts and supports research to develop vaccines, therapeutics and diagnostics to help understand, treat, and prevent infectious, immunologic, …

Vaccine

Vaccine Asia Live: Novel Vaccines for Emerging Diseases

Most vaccines developed target infectious diseases and cancer, with cancer vaccines being listed more under therapeutic vaccines. To enlighten us on vaccines for infectious diseases, Ms Zhang Xiaoshu, Director of Business Development at BravoBio, China, presented on the topic of Novel Vaccines for Emerging Diseases. BravoBio was founded in 2011 with its  headquarters in Shanghai and multiple sites in China. …

Vaccine Asia Live: Recombinant Lipoimmunogen-based therapeutic HPV Vaccine

Human Papilloma Virus(HPV) is a DNA virus that can cause skin & genital warts as well as cervical and osopharyngeal cancers. In the US, there is an increasing trend in cervical cancer in women and osopharyngeal cancer in men.  To make things worse, there are no treatments available for HPV infection. Thus, HPV vaccines have become the most common mode …

Vaccine Asia Live: Forging Strategic Partnership for R&D to Meet High Demands for Vaccines in Asia

As a unique feature of Terrapinn conferences, the roundtable discussions serve as an interactive platform for meaningful discussion. At World Vaccine Congress Asia 2014, Do Tuan Dat, President & General Director of Vabiotech, Vietnam, moderated the discussion on the topic of “Forging Strategic Partnership for R&D to Meet High Demands for Vaccines in Asia”. A consensus was reached among the …

Round up from the World Vaccine Congress 2014

  So the World Vaccine Congress is over for its 14th year! With 80+ speakers, 40+ sponsors and over 60 sessions of scientific, corporate development and future-looking content, it was a busy few days! Opening with Dr Gregory Poland from the Mayo Clinic talking about the future of vaccinology, right from the start the focus was on what will be …

Download presentation: NIAID Resources and Opportunities for Vaccine Research

In November 2012 over 200 delegates participated in the 13th Annual World Vaccine Congress Lyon in France. This event brings together vaccine leaders and policy makers from around the globe. Attendees at this highly successful event were fortunate enough to hear this exciting presentation delivered by Cristina Cassetti, Ph.D, Program Officer, Division of Microbiology and Infectious Diseases, National Institute of …

Presentation download: Developing effective technologies using bacterial poison-antidote genes for the production of recombinant vaccines in E.coli

Delphi Genetics is an expert service provider for gene expression, DNA cloning and recombinant protein production. Work to develop research kits for Molecular Cloning and Protein Expression based on proprietary technologies, products sold directly by the company and globally distributed. The company also licenses technologies for biopharmaceutical applications. Philippe Gabant, Head of Business Development, Delphi Genetics, joined us at the …

Presentation download: Strategies to develop a stable packaging cell line and process

Dr Mark Cutler, Associate Director, Pfizer Vaccine Research, joined us at the World Vaccine Cell Culture Congress in Washington in 2012 to present on strategies to develop a stable packaging cell line and process, leading to the successful generation and identification of stable Vero-G cell lines. Testing and characterization of cell lines is intrinsic to this development process and takes …

#wvcusa – The future of #vaccines: Challenges and Opportunities by Merck & Co

Dr. Casimiro is a Director of Vaccine Basic Research at Merck & Co. and he delivered a great presentation  about the future of vaccines highlighting the main challenges and opportunities facing the industry at the World Vaccine Congress. Many challenges remain ahead of us for discovery and development according to Dr. Casimiro. There are emerging and re-emerging infectious diseases, there …